Result of PTS III (CRC) interview DengiAll.

Department of Community Medicine Atal Bihari Vajpayec Institute of Medical Sciences & Dr Ram Manohar Lohia Hospital, New Delhi~ I 10001 A Phase 111, Multicentre, Randomized, Oouble-Blind, Placebo-Controlled Study to Evaluate the Efficacy, lmmunogenicity and Safety of Single Dose of Dengue Tetravalent Vaccine, Live Attenuated (Recombinant, Lyophilized) - "DengiALL" of Panacea Biotec Limited in Health Indian Adults. Principal Investigator: Dr . Neclam Roy Funding Agency : ICMR Minutes of the Selection Committee for the post of Pro ,ject Technical Support 111 (Clinical Research Coordinator) ;\ committee consisting of the following member s under the chairmanship of Dr. 11. S . Mahapatra. the Principal. __ ABVIMS & Dr RM L Hospital wa s formed with the approval of the competent authority for selection of Project Technical Support Ill (Clinical Research Coordinator) for the above mentioned project : I. Dr. Neelam Roy , Pl , DengiAII Trial, Director Prof & I lead , Community Medicine 2 . Dr. Mala Chhabra. Co- Pl, DengiAII Trial , Consultant, Microbiology 3 . Dr. Vijay Kumar. Co-Pl.

Read the full notice

Open full screen Open on the official site